$IDPH Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOGEN INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in BIOGEN INC.. Get notifications about new insider transactions in BIOGEN INC. for free.
Page: < prev 1 2 3 4 5 6 ... 34 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 14 2020 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Buy | M | 0.00 | 1,056 | 0 | 5,021 | 4 K to 5 K (+26.63 %) |
| Feb 14 2020 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Payment of Exercise | F | 331.76 | 286 | 94,883 | 3,965 | 4.3 K to 4 K (-6.73 %) |
| Feb 14 2020 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Buy | M | 0.00 | 974 | 0 | 4,251 | 3.3 K to 4.3 K (+29.72 %) |
| Feb 14 2020 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Payment of Exercise | F | 331.76 | 455 | 150,951 | 3,277 | 3.7 K to 3.3 K (-12.19 %) |
| Feb 14 2020 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Buy | M | 0.00 | 1,517 | 0 | 3,732 | 2.2 K to 3.7 K (+68.49 %) |
| Feb 14 2020 | IDPH | BIOGEN INC. | Galdes Alphonse | EVP Pharmaceutical ... | Option Exercise | J | 0.00 | 420 | 0 | 1,562 | |
| Feb 14 2020 | IDPH | BIOGEN INC. | Galdes Alphonse | EVP Pharmaceutical ... | Option Exercise | M | 0.00 | 358 | 0 | 1,982 | |
| Feb 14 2020 | IDPH | BIOGEN INC. | Galdes Alphonse | EVP Pharmaceutical ... | Option Exercise | J | 0.00 | 294 | 0 | 608 | |
| Feb 14 2020 | IDPH | BIOGEN INC. | Galdes Alphonse | EVP Pharmaceutical ... | Option Exercise | M | 0.00 | 312 | 0 | 902 | |
| Feb 14 2020 | IDPH | BIOGEN INC. | Galdes Alphonse | EVP Pharmaceutical ... | Option Exercise | M | 0.00 | 484 | 0 | 0 | |
| Feb 14 2020 | IDPH | BIOGEN INC. | Galdes Alphonse | EVP Pharmaceutical ... | Option Exercise | A | 0.00 | 6,780 | 0 | 6,780 | |
| Feb 14 2020 | IDPH | BIOGEN INC. | Galdes Alphonse | EVP Pharmaceutical ... | Payment of Exercise | F | 331.76 | 106 | 35,167 | 2,231 | 2.3 K to 2.2 K (-4.54 %) |
| Feb 14 2020 | IDPH | BIOGEN INC. | Galdes Alphonse | EVP Pharmaceutical ... | Buy | M | 0.00 | 358 | 0 | 2,337 | 2 K to 2.3 K (+18.09 %) |
| Feb 14 2020 | IDPH | BIOGEN INC. | Galdes Alphonse | EVP Pharmaceutical ... | Payment of Exercise | F | 331.76 | 92 | 30,522 | 1,979 | 2.1 K to 2 K (-4.44 %) |
| Feb 14 2020 | IDPH | BIOGEN INC. | Galdes Alphonse | EVP Pharmaceutical ... | Buy | M | 0.00 | 312 | 0 | 2,071 | 1.8 K to 2.1 K (+17.74 %) |
| Feb 14 2020 | IDPH | BIOGEN INC. | Galdes Alphonse | EVP Pharmaceutical ... | Payment of Exercise | F | 331.76 | 153 | 50,759 | 1,759 | 1.9 K to 1.8 K (-8.00 %) |
| Feb 14 2020 | IDPH | BIOGEN INC. | Galdes Alphonse | EVP Pharmaceutical ... | Buy | M | 0.00 | 484 | 0 | 1,912 | 1.4 K to 1.9 K (+33.89 %) |
| Feb 14 2020 | IDPH | BIOGEN INC. | CAPELLO JEFFREY D | EVP & Chief Financi ... | Option Exercise | J | 0.00 | 2,253 | 0 | 8,348 | |
| Feb 14 2020 | IDPH | BIOGEN INC. | CAPELLO JEFFREY D | EVP & Chief Financi ... | Option Exercise | M | 0.00 | 1,919 | 0 | 10,601 | |
| Feb 14 2020 | IDPH | BIOGEN INC. | CAPELLO JEFFREY D | EVP & Chief Financi ... | Option Exercise | A | 0.00 | 10,550 | 0 | 10,550 | |
| Feb 14 2020 | IDPH | BIOGEN INC. | CAPELLO JEFFREY D | EVP & Chief Financi ... | Payment of Exercise | F | 331.76 | 614 | 203,701 | 3,118 | 3.7 K to 3.1 K (-16.45 %) |
| Feb 14 2020 | IDPH | BIOGEN INC. | CAPELLO JEFFREY D | EVP & Chief Financi ... | Buy | M | 0.00 | 1,919 | 0 | 3,732 | 1.8 K to 3.7 K (+105.85 %) |
| Feb 14 2020 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Option Exercise | J | 0.00 | 1,803 | 0 | 6,682 | |
| Feb 14 2020 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Option Exercise | M | 0.00 | 1,535 | 0 | 8,485 | |
| Feb 14 2020 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Option Exercise | M | 0.00 | 2,697 | 0 | 0 | |
| Feb 14 2020 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Option Exercise | J | 0.00 | 1,633 | 0 | 3,374 | |
| Feb 14 2020 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Option Exercise | M | 0.00 | 1,735 | 0 | 5,007 | |
| Feb 14 2020 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Option Exercise | A | 0.00 | 9,650 | 0 | 9,650 | |
| Feb 14 2020 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Payment of Exercise | F | 331.76 | 681 | 225,929 | 35,708 | 36.4 K to 35.7 K (-1.87 %) |
| Feb 14 2020 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Buy | M | 0.00 | 1,535 | 0 | 36,389 | 34.9 K to 36.4 K (+4.40 %) |
| Feb 14 2020 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Payment of Exercise | F | 331.76 | 798 | 264,744 | 34,854 | 35.7 K to 34.9 K (-2.24 %) |
| Feb 14 2020 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Buy | M | 0.00 | 2,697 | 0 | 35,652 | 33 K to 35.7 K (+8.18 %) |
| Feb 14 2020 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Payment of Exercise | F | 331.76 | 756 | 250,811 | 32,955 | 33.7 K to 33 K (-2.24 %) |
| Feb 14 2020 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Buy | M | 0.00 | 1,735 | 0 | 33,711 | 32 K to 33.7 K (+5.43 %) |
| Feb 14 2020 | IDPH | BIOGEN INC. | Vounatsos Michel | Chief Executive Off ... | Option Exercise | A | 0.00 | 37,680 | 0 | 37,680 | |
| Feb 14 2020 | IDPH | BIOGEN INC. | Vounatsos Michel | Chief Executive Off ... | Option Exercise | J | 0.00 | 6,762 | 0 | 25,048 | |
| Feb 14 2020 | IDPH | BIOGEN INC. | Vounatsos Michel | Chief Executive Off ... | Option Exercise | M | 0.00 | 5,760 | 0 | 31,810 | |
| Feb 14 2020 | IDPH | BIOGEN INC. | Vounatsos Michel | Chief Executive Off ... | Option Exercise | J | 0.00 | 5,870 | 0 | 12,112 | |
| Feb 14 2020 | IDPH | BIOGEN INC. | Vounatsos Michel | Chief Executive Off ... | Option Exercise | M | 0.00 | 6,234 | 0 | 17,982 | |
| Feb 14 2020 | IDPH | BIOGEN INC. | Vounatsos Michel | Chief Executive Off ... | Payment of Exercise | F | 331.76 | 2,555 | 847,647 | 28,928 | 31.5 K to 28.9 K (-8.12 %) |
| Feb 14 2020 | IDPH | BIOGEN INC. | Vounatsos Michel | Chief Executive Off ... | Buy | M | 0.00 | 5,760 | 0 | 31,483 | 25.7 K to 31.5 K (+22.39 %) |
| Feb 14 2020 | IDPH | BIOGEN INC. | Vounatsos Michel | Chief Executive Off ... | Payment of Exercise | F | 331.76 | 2,340 | 776,318 | 25,723 | 28.1 K to 25.7 K (-8.34 %) |
| Feb 14 2020 | IDPH | BIOGEN INC. | Vounatsos Michel | Chief Executive Off ... | Buy | M | 0.00 | 6,234 | 0 | 28,063 | 21.8 K to 28.1 K (+28.56 %) |
| Feb 14 2020 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Research & Dev ... | Option Exercise | A | 0.00 | 12,060 | 0 | 12,060 | |
| Feb 14 2020 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Research & Dev ... | Option Exercise | J | 0.00 | 1,859 | 0 | 6,888 | |
| Feb 14 2020 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Research & Dev ... | Option Exercise | M | 0.00 | 1,583 | 0 | 8,747 | |
| Feb 14 2020 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Research & Dev ... | Option Exercise | J | 0.00 | 1,340 | 0 | 2,766 | |
| Feb 14 2020 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Research & Dev ... | Option Exercise | M | 0.00 | 1,422 | 0 | 4,106 | |
| Feb 14 2020 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Research & Dev ... | Option Exercise | M | 0.00 | 2,211 | 0 | 0 | |
| Feb 14 2020 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Research & Dev ... | Payment of Exercise | F | 331.76 | 703 | 233,227 | 13,806 | 14.5 K to 13.8 K (-4.85 %) |
| Feb 14 2020 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Research & Dev ... | Buy | M | 0.00 | 1,583 | 0 | 14,509 | 12.9 K to 14.5 K (+12.25 %) |
| Feb 14 2020 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Research & Dev ... | Payment of Exercise | F | 331.76 | 538 | 178,487 | 12,926 | 13.5 K to 12.9 K (-4.00 %) |
| Feb 14 2020 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Research & Dev ... | Buy | M | 0.00 | 1,422 | 0 | 13,464 | 12 K to 13.5 K (+11.81 %) |
| Feb 14 2020 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Research & Dev ... | Payment of Exercise | F | 331.76 | 660 | 218,962 | 12,042 | 12.7 K to 12 K (-5.20 %) |
| Feb 14 2020 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Research & Dev ... | Buy | M | 0.00 | 2,211 | 0 | 12,702 | 10.5 K to 12.7 K (+21.08 %) |
| Jan 06 2020 | IDPH | BIOGEN INC. | CAPELLO JEFFREY D | EVP & Chief Financi ... | Option Exercise | J | 0.00 | 1,690 | 0 | 2,996 | |
| Jan 06 2020 | IDPH | BIOGEN INC. | CAPELLO JEFFREY D | EVP & Chief Financi ... | Option Exercise | M | 0.00 | 1,302 | 0 | 4,686 | |
| Jan 06 2020 | IDPH | BIOGEN INC. | CAPELLO JEFFREY D | EVP & Chief Financi ... | Payment of Exercise | F | 294.20 | 406 | 119,445 | 1,813 | 2.2 K to 1.8 K (-18.30 %) |
| Jan 06 2020 | IDPH | BIOGEN INC. | CAPELLO JEFFREY D | EVP & Chief Financi ... | Buy | M | 0.00 | 1,302 | 0 | 2,219 | 917 to 2.2 K (+141.98 %) |
| Dec 05 2019 | IDPH | BIOGEN INC. | Kramer Robin | VP, Chief Accountin ... | Option Exercise | J | 0.00 | 92 | 0 | 354 | |
| Dec 05 2019 | IDPH | BIOGEN INC. | Kramer Robin | VP, Chief Accountin ... | Option Exercise | M | 0.00 | 84 | 0 | 446 | |
| Dec 05 2019 | IDPH | BIOGEN INC. | Kramer Robin | VP, Chief Accountin ... | Payment of Exercise | F | 290.70 | 25 | 7,268 | 150 | 175 to 150 (-14.29 %) |
| Dec 05 2019 | IDPH | BIOGEN INC. | Kramer Robin | VP, Chief Accountin ... | Buy | M | 0.00 | 84 | 0 | 175 | 91 to 175 (+92.31 %) |
| Dec 03 2019 | IDPH | BIOGEN INC. | Guindo Chirfi | EVP Glob. Prod Stra ... | Option Exercise | J | 0.00 | 625 | 0 | 1,174 | |
| Dec 03 2019 | IDPH | BIOGEN INC. | Guindo Chirfi | EVP Glob. Prod Stra ... | Option Exercise | M | 0.00 | 543 | 0 | 1,799 | |
| Dec 03 2019 | IDPH | BIOGEN INC. | Guindo Chirfi | EVP Glob. Prod Stra ... | Payment of Exercise | F | 299.81 | 160 | 47,970 | 2,695 | 2.9 K to 2.7 K (-5.60 %) |
| Dec 03 2019 | IDPH | BIOGEN INC. | Guindo Chirfi | EVP Glob. Prod Stra ... | Buy | M | 0.00 | 543 | 0 | 2,855 | 2.3 K to 2.9 K (+23.49 %) |
| Dec 03 2019 | IDPH | BIOGEN INC. | Guindo Chirfi | EVP Glob. Prod Stra ... | Payment of Exercise | F | 299.81 | 231 | 69,256 | 2,312 | 2.5 K to 2.3 K (-9.08 %) |
| Dec 03 2019 | IDPH | BIOGEN INC. | Posner Brian S | Director | Sell | S | 292.35 | 1,055 | 308,429 | 6,995 | 8.1 K to 7 K (-13.11 %) |
| Aug 05 2019 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Option Exercise | J | 0.00 | 247 | 0 | 428 | |
| Aug 05 2019 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Option Exercise | M | 0.00 | 179 | 0 | 675 | |
| Aug 05 2019 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Payment of Exercise | F | 243.06 | 80 | 19,445 | 2,215 | 2.3 K to 2.2 K (-3.49 %) |
| Aug 05 2019 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Buy | M | 0.00 | 179 | 0 | 2,295 | 2.1 K to 2.3 K (+8.46 %) |
| Aug 05 2019 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Payment of Exercise | F | 243.06 | 128 | 31,112 | 2,116 | 2.2 K to 2.1 K (-5.70 %) |
| Jul 05 2019 | IDPH | BIOGEN INC. | Karp Daniel | EVP, Corporate Deve ... | Option Exercise | J | 0.00 | 390 | 0 | 1,174 | |
| Jul 05 2019 | IDPH | BIOGEN INC. | Karp Daniel | EVP, Corporate Deve ... | Option Exercise | M | 0.00 | 196 | 0 | 1,564 | |
| Jul 05 2019 | IDPH | BIOGEN INC. | Karp Daniel | EVP, Corporate Deve ... | Payment of Exercise | F | 236.37 | 58 | 13,709 | 264 | 322 to 264 (-18.01 %) |
| Jul 05 2019 | IDPH | BIOGEN INC. | Karp Daniel | EVP, Corporate Deve ... | Buy | M | 0.00 | 196 | 0 | 322 | 126 to 322 (+155.56 %) |
| Jun 20 2019 | IDPH | BIOGEN INC. | Mantas Jesus B | Director | Grant | A | 0.00 | 1,155 | 0 | 1,155 | 0 to 1.2 K |
| Jun 20 2019 | IDPH | BIOGEN INC. | HAWKINS WILLIAM A | Director | Grant | A | 0.00 | 1,155 | 0 | 1,155 | 0 to 1.2 K |
| Jun 20 2019 | IDPH | BIOGEN INC. | SHERWIN STEPHEN A | Director | Grant | A | 0.00 | 1,155 | 0 | 6,319 | 5.2 K to 6.3 K (+22.37 %) |
| Jun 20 2019 | IDPH | BIOGEN INC. | SCHENK LYNN | Director | Grant | A | 0.00 | 1,155 | 0 | 9,032 | 7.9 K to 9 K (+14.66 %) |
| Jun 20 2019 | IDPH | BIOGEN INC. | Rowinsky Eric K | Director | Grant | A | 0.00 | 1,155 | 0 | 16,179 | 15 K to 16.2 K (+7.69 %) |
| Jun 20 2019 | IDPH | BIOGEN INC. | Posner Brian S | Director | Grant | A | 0.00 | 1,155 | 0 | 8,050 | 6.9 K to 8.1 K (+16.75 %) |
| Jun 20 2019 | IDPH | BIOGEN INC. | PAPADOPOULOS STELIOS | Director | Grant | A | 0.00 | 1,905 | 0 | 5,095 | 3.2 K to 5.1 K (+59.72 %) |
| Jun 20 2019 | IDPH | BIOGEN INC. | PANGIA ROBERT W | Director | Grant | A | 0.00 | 1,155 | 0 | 19,742 | 18.6 K to 19.7 K (+6.21 %) |
| Jun 20 2019 | IDPH | BIOGEN INC. | Mulligan Richard | Director | Grant | A | 0.00 | 1,155 | 0 | 12,064 | 10.9 K to 12.1 K (+10.59 %) |
| Jun 20 2019 | IDPH | BIOGEN INC. | LEAMING NANCY | Director | Grant | A | 0.00 | 1,155 | 0 | 12,098 | 10.9 K to 12.1 K (+10.55 %) |
| Jun 20 2019 | IDPH | BIOGEN INC. | DORSA CAROLINE | Director | Grant | A | 0.00 | 1,155 | 0 | 20,207 | 19.1 K to 20.2 K (+6.06 %) |
| Jun 20 2019 | IDPH | BIOGEN INC. | DENNER ALEXANDER J | Director | Grant | A | 0.00 | 1,155 | 0 | 12,064 | 10.9 K to 12.1 K (+10.59 %) |
| Jun 04 2019 | IDPH | BIOGEN INC. | Ehlers Michael D | EVP, Research and D ... | Option Exercise | J | 0.00 | 1,376 | 0 | 0 | |
| Jun 04 2019 | IDPH | BIOGEN INC. | Ehlers Michael D | EVP, Research and D ... | Option Exercise | M | 0.00 | 1,126 | 0 | 1,376 | |
| Jun 04 2019 | IDPH | BIOGEN INC. | Ehlers Michael D | EVP, Research and D ... | Payment of Exercise | F | 219.29 | 500 | 109,645 | 8,025 | 8.5 K to 8 K (-5.87 %) |
| Jun 04 2019 | IDPH | BIOGEN INC. | Ehlers Michael D | EVP, Research and D ... | Buy | M | 0.00 | 1,126 | 0 | 8,525 | 7.4 K to 8.5 K (+15.22 %) |
| Jun 04 2019 | IDPH | BIOGEN INC. | Ehlers Michael D | EVP, Research and D ... | Payment of Exercise | F | 219.29 | 460 | 100,873 | 7,399 | 7.9 K to 7.4 K (-5.85 %) |
| May 06 2019 | IDPH | BIOGEN INC. | Vounatsos Michel | Chief Executive Off ... | Option Exercise | J | 0.00 | 1,772 | 0 | 0 | |
| May 06 2019 | IDPH | BIOGEN INC. | Vounatsos Michel | Chief Executive Off ... | Option Exercise | M | 0.00 | 1,480 | 0 | 1,772 | |
| May 06 2019 | IDPH | BIOGEN INC. | Vounatsos Michel | Chief Executive Off ... | Payment of Exercise | F | 230.52 | 658 | 151,682 | 21,829 | 22.5 K to 21.8 K (-2.93 %) |
| May 06 2019 | IDPH | BIOGEN INC. | Vounatsos Michel | Chief Executive Off ... | Buy | M | 0.00 | 1,480 | 0 | 22,487 | 21 K to 22.5 K (+7.05 %) |
| May 02 2019 | IDPH | BIOGEN INC. | DENNER ALEXANDER J | Director | Buy | P | 231.24 | 38,000 | 8,787,120 | 643,000 | 605 K to 643 K (+6.28 %) |
| May 02 2019 | IDPH | BIOGEN INC. | DENNER ALEXANDER J | Director | Buy | P | 229.46 | 30,000 | 6,883,800 | 605,000 | 575 K to 605 K (+5.22 %) |
| May 02 2019 | IDPH | BIOGEN INC. | DENNER ALEXANDER J | Director | Buy | P | 229.25 | 50,342 | 11,540,904 | 575,000 | 524.7 K to 575 K (+9.60 %) |
| May 02 2019 | IDPH | BIOGEN INC. | Vounatsos Michel | Chief Executive Off ... | Buy | P | 231.48 | 4,351 | 1,007,169 | 21,007 | 16.7 K to 21 K (+26.12 %) |
| Mar 05 2019 | IDPH | BIOGEN INC. | McKenzie Paul | EVP Pharmaceutical ... | Option Exercise | J | 0.00 | 280 | 0 | 0 | |
| Mar 05 2019 | IDPH | BIOGEN INC. | McKenzie Paul | EVP Pharmaceutical ... | Option Exercise | M | 0.00 | 568 | 0 | 280 | |
| Mar 05 2019 | IDPH | BIOGEN INC. | McKenzie Paul | EVP Pharmaceutical ... | Payment of Exercise | F | 334.10 | 253 | 84,527 | 7,235 | 7.5 K to 7.2 K (-3.38 %) |
| Mar 05 2019 | IDPH | BIOGEN INC. | McKenzie Paul | EVP Pharmaceutical ... | Buy | M | 0.00 | 568 | 0 | 7,488 | 6.9 K to 7.5 K (+8.21 %) |
| Mar 05 2019 | IDPH | BIOGEN INC. | McKenzie Paul | EVP Pharmaceutical ... | Payment of Exercise | F | 334.10 | 405 | 135,311 | 6,920 | 7.3 K to 6.9 K (-5.53 %) |
| Feb 26 2019 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Option Exercise | M | 49.65 | 6,395 | 317,512 | 0 | |
| Feb 26 2019 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Option Exercise | J | 0.00 | 819 | 0 | 0 | |
| Feb 26 2019 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Option Exercise | M | 0.00 | 1,663 | 0 | 819 | |
| Feb 26 2019 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Payment of Exercise | F | 325.33 | 739 | 240,419 | 31,976 | 32.7 K to 32 K (-2.26 %) |
| Feb 26 2019 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Payment of Exercise | F | 325.33 | 3,370 | 1,096,362 | 32,715 | 36.1 K to 32.7 K (-9.34 %) |
| Feb 26 2019 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Buy | M | 48.52 | 6,395 | 310,285 | 36,085 | 29.7 K to 36.1 K (+21.54 %) |
| Feb 26 2019 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Buy | M | 0.00 | 1,663 | 0 | 29,690 | 28 K to 29.7 K (+5.93 %) |
| Feb 26 2019 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Chief Medical ... | Option Exercise | J | 0.00 | 819 | 0 | 0 | |
| Feb 26 2019 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Chief Medical ... | Option Exercise | M | 0.00 | 1,663 | 0 | 819 | |
| Feb 26 2019 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Chief Medical ... | Payment of Exercise | F | 325.33 | 739 | 240,419 | 10,409 | 11.1 K to 10.4 K (-6.63 %) |
| Feb 26 2019 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Chief Medical ... | Buy | M | 0.00 | 1,663 | 0 | 11,148 | 9.5 K to 11.1 K (+17.53 %) |
| Feb 20 2019 | IDPH | BIOGEN INC. | Vounatsos Michel | Chief Executive Off ... | Option Exercise | J | 0.00 | 3,229 | 0 | 8,504 | |
| Feb 20 2019 | IDPH | BIOGEN INC. | Vounatsos Michel | Chief Executive Off ... | Option Exercise | M | 0.00 | 5,269 | 0 | 11,733 | |
| Feb 20 2019 | IDPH | BIOGEN INC. | Vounatsos Michel | Chief Executive Off ... | Payment of Exercise | F | 332.87 | 2,340 | 778,916 | 16,574 | 18.9 K to 16.6 K (-12.37 %) |
| Feb 20 2019 | IDPH | BIOGEN INC. | Vounatsos Michel | Chief Executive Off ... | Buy | M | 0.00 | 5,269 | 0 | 18,914 | 13.6 K to 18.9 K (+38.61 %) |
| Feb 20 2019 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Chief Medical ... | Option Exercise | J | 0.00 | 808 | 0 | 2,128 | |
| Feb 20 2019 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Chief Medical ... | Option Exercise | M | 0.00 | 1,318 | 0 | 2,936 | |
| Feb 20 2019 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Chief Medical ... | Payment of Exercise | F | 332.87 | 586 | 195,062 | 9,485 | 10.1 K to 9.5 K (-5.82 %) |
| Feb 20 2019 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Chief Medical ... | Buy | M | 0.00 | 1,318 | 0 | 10,071 | 8.8 K to 10.1 K (+15.06 %) |
| Feb 20 2019 | IDPH | BIOGEN INC. | McKenzie Paul | EVP Pharmaceutical ... | Option Exercise | J | 0.00 | 888 | 0 | 2,338 | |
| Feb 20 2019 | IDPH | BIOGEN INC. | McKenzie Paul | EVP Pharmaceutical ... | Option Exercise | M | 0.00 | 1,448 | 0 | 3,226 | |
| Feb 20 2019 | IDPH | BIOGEN INC. | McKenzie Paul | EVP Pharmaceutical ... | Payment of Exercise | F | 332.87 | 643 | 214,035 | 7,325 | 8 K to 7.3 K (-8.07 %) |
| Feb 20 2019 | IDPH | BIOGEN INC. | McKenzie Paul | EVP Pharmaceutical ... | Buy | M | 0.00 | 1,448 | 0 | 7,968 | 6.5 K to 8 K (+22.21 %) |
| Feb 20 2019 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Option Exercise | J | 0.00 | 1,033 | 0 | 2,724 | |
| Feb 20 2019 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Option Exercise | M | 0.00 | 1,685 | 0 | 3,757 | |
| Feb 20 2019 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Payment of Exercise | F | 332.87 | 749 | 249,320 | 28,027 | 28.8 K to 28 K (-2.60 %) |
| Feb 20 2019 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Buy | M | 0.00 | 1,685 | 0 | 28,776 | 27.1 K to 28.8 K (+6.22 %) |
| Feb 15 2019 | IDPH | BIOGEN INC. | Posner Brian S | Director | Gift | G | 0.00 | 315 | 0 | 6,895 | 7.2 K to 6.9 K (-4.37 %) |
| Feb 14 2019 | IDPH | BIOGEN INC. | Vounatsos Michel | Chief Executive Off ... | Option Exercise | A | 0.00 | 37,570 | 0 | 37,570 | |
| Feb 14 2019 | IDPH | BIOGEN INC. | Vounatsos Michel | Chief Executive Off ... | Option Exercise | J | 0.00 | 5,205 | 0 | 24,216 | |
| Feb 14 2019 | IDPH | BIOGEN INC. | Vounatsos Michel | Chief Executive Off ... | Option Exercise | M | 0.00 | 6,899 | 0 | 29,421 | |
| Feb 14 2019 | IDPH | BIOGEN INC. | Vounatsos Michel | Chief Executive Off ... | Payment of Exercise | F | 319.43 | 2,622 | 837,545 | 13,645 | 16.3 K to 13.6 K (-16.12 %) |
| Feb 14 2019 | IDPH | BIOGEN INC. | Vounatsos Michel | Chief Executive Off ... | Buy | M | 0.00 | 6,899 | 0 | 16,267 | 9.4 K to 16.3 K (+73.64 %) |
| Feb 14 2019 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Chief Medical ... | Option Exercise | J | 0.00 | 1,188 | 0 | 5,528 | |
| Feb 14 2019 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Chief Medical ... | Option Exercise | M | 0.00 | 1,574 | 0 | 6,716 | |
| Feb 14 2019 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Chief Medical ... | Option Exercise | J | 0.00 | 1,453 | 0 | 0 | |
| Feb 14 2019 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Chief Medical ... | Option Exercise | M | 0.00 | 1,965 | 0 | 1,453 | |
| Feb 14 2019 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Chief Medical ... | Option Exercise | M | 0.00 | 1,104 | 0 | 2,211 | |
| Feb 14 2019 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Chief Medical ... | Option Exercise | A | 0.00 | 10,330 | 0 | 10,330 | |
| Feb 14 2019 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Chief Medical ... | Payment of Exercise | F | 319.43 | 699 | 223,282 | 8,753 | 9.5 K to 8.8 K (-7.40 %) |
| Feb 14 2019 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Chief Medical ... | Buy | M | 0.00 | 1,574 | 0 | 9,452 | 7.9 K to 9.5 K (+19.98 %) |
| Feb 14 2019 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Chief Medical ... | Payment of Exercise | F | 319.43 | 873 | 278,862 | 7,878 | 8.8 K to 7.9 K (-9.98 %) |